INTRODUCTION
============

The inner ear is a complex sensory organ composed of five sensory patches specialized for hearing and balance. The organ of Corti in the cochlea is responsible for hearing. In the vestibule, three cristae (anterior, lateral, and posterior) detect angular movements and two maculae (utricle and saccule) detect linear acceleration. These five sensory patches house mechanosensory hair cells that recognize and convert the mechanical stimuli originating from sound or angular/linear movements into electrical signals. These signals are then conveyed to neurons of the cochlear and vestibular ganglia, which transmit the signals to the brain. Formation of a functional inner ear requires tight regulation of genes important to developmental processes, including fate determination, differentiation, and morphogenesis ([@b18-molce-41-7-695]).

Recently, epigenetic regulations have been shown to play important roles in development and disease ([@b7-molce-41-7-695]). Epigenetic mechanisms influence gene expression patterns by modulating DNA methylation status and histone modifications. An essential epigenetic component, CCCTC-binding factor (CTCF) plays a primary role in the global organization of chromatic architecture. CTCF has been implicated in various cellular processes, including transcriptional regulation, insulation, X chromosome inactivation, and RNA splicing ([@b7-molce-41-7-695]; [@b10-molce-41-7-695]). Furthermore, CTCF has been found to play crucial roles in limb and brain development: Specific deletion of *Ctcf* in the mesenchyme of a developing limb was found to cause massive cell death, resulting in a loss of limb structures ([@b14-molce-41-7-695]). In addition, CTCF was shown to play essential roles during early cortex formation by balancing cell proliferation and differentiation and by promoting cell survival of neuroprogenitors ([@b17-molce-41-7-695]). Further, in postmitotic neurons in the telencephalon, *Ctcf* deficiency elicited alterations in *Pcdh* gene expression that led to defects in dendritic arborization and spine density ([@b2-molce-41-7-695]). The function of CTCF, however, in inner ear development has not been examined.

In this study, we applied a conditional knockout (cKO) mouse system to determine the role of CTCF in inner ear development. Our results highlight an essential association between CTCF and otic neurogenesis and posit CTCF as a crucial homeostatic regulator of inner ear by regulating a master neurogenic regulator, *Neurog1*.

MATERIALS AND METHODS
=====================

Animals
-------

The mice utilized in this study carried a conditional Ctcf allele (*Ctcf^fl/fl^*) was described in our previous study ([@b4-molce-41-7-695]). *Ctcf^fl/fl^* mice were bred with *Tg(Pax2-Cre)1Akg/Mmnc* (*Pax2-Cre*; MMRRC, NC) mice to obtain inner ear specific conditional knockout mutants ([@b6-molce-41-7-695]). All animal protocols were approved by the Institutional Animal Care and Use Committee at Yonsei University College of Medicine.

Paint-fill injection, *in situ* hybridization, and immunostaining
-----------------------------------------------------------------

Paint-fill analysis, *in situ* hybridization, and immunostaining were performed as described previously ([@b5-molce-41-7-695]; [@b17-molce-41-7-695]).

Microarray
----------

Total RNA was extracted from control and *Ctcf* cKO otocysts at E10.5 using TRIZOL reagent according to the manufacturer's instructions (Invitrogen, USA). Sample preparation and microarray data analyses were performed as described previously ([@b4-molce-41-7-695]). The microarray data were validated by qPCR. The primers used for qPCR are listed in [Supplementary Table S3](#s1-molce-41-7-695){ref-type="supplementary-material"}.

Cell culture
------------

P19 cells were maintained in alpha minimum essential medium (Welgene, Korea) supplemented with 10% heat-inactivated fetal bovine serum (Welgene) and 100 U/ml of penicillin/streptomycin (Welgene).

Chromatin immunoprecipitation (ChIP)
------------------------------------

ChIP assays were performed as described previously ([@b8-molce-41-7-695]). The sequences of the primers for the *Neurog1* locus are listed in [Supplementary Table S4](#s1-molce-41-7-695){ref-type="supplementary-material"}.

RESULTS
=======

*Ctcf* deficiency causes severe developmental defects of the inner ear
----------------------------------------------------------------------

To investigate the role of CTCF in inner ear development, we conditionally deleted *Ctcf* in the otic epithelium by crossing *Ctcf^fl/fl^* mice with *Pax2-Cre* mice ([@b6-molce-41-7-695]). The inner ears of *Pax2-Cre; Ctcf^fl/fl^* (*Ctcf* cKO) embryos were severely malformed, such that no discernible vestibular structures were observed, except for the posterior canal/ampulla, and the cochlear duct was shortened without its typical coiled structure ([Figs. 1A--1C](#f1-molce-41-7-695){ref-type="fig"} vs [Figs. 1D--1F](#f1-molce-41-7-695){ref-type="fig"}).

As stated above, inactivation of *Ctcf* in the developing limb and brain has been shown to cause massive cell death, leading to loss of tissue and structures ([@b14-molce-41-7-695]; [@b17-molce-41-7-695]). We, thus, sought to determine whether the morphological defects observed in *Ctcf*-deficient inner ears ([Fig. 1](#f1-molce-41-7-695){ref-type="fig"}) were due to increased cell death. Compared to controls, TUNEL-positivity (marker of apoptosis) greatly increased among *Ctcf* cKO otocysts mostly in the posterior regions ([Figs. 1I and 1M](#f1-molce-41-7-695){ref-type="fig"}, red dotted line). Moreover, cell proliferation decreased in the absence of functional CTCF, as reflected by fewer thymidine analog 5-ethynyl-2′-deoxyuridine (EdU)-positive cells among the otocysts ([Figs. 1J and 1N](#f1-molce-41-7-695){ref-type="fig"}, white dotted line). These results suggest that CTCF plays important roles in the promotion of cell survival and cell proliferation during inner ear development, which may account for the morphological defects observed in the *Ctcf* cKO inner ears.

Spiral ganglion neurons are lost in the inner ears *of Ctcf*-deficient mouse embryos
------------------------------------------------------------------------------------

We then examined whether development of the sensory patches or spiral ganglion neurons residing within the inner ear are compromised in the malformed inner ears of *Ctcf* cKO mouse embryos. We used *Bone morphogenetic protein 4* (*Bmp4*) and *Lunatic fringe* (*Lfng*) as molecular markers for cristae and maculae in the developing vestibule, respectively ([Figs. 2A and 2E](#f2-molce-41-7-695){ref-type="fig"}) ([@b5-molce-41-7-695]). In *Ctcf* cKO ears, *Bmp4* expression was observed in the posterior crista region ([Fig. 2D](#f2-molce-41-7-695){ref-type="fig"}, arrow), and *Lfng* expression was observed in the anterior edge ([Fig. 2G](#f2-molce-41-7-695){ref-type="fig"}). We also used *Bmp4* and *Lfng* to delineate the lateral epithelial ridge and the organ of Corti in the cochlea, respectively ([Figs. 2B and 2F](#f2-molce-41-7-695){ref-type="fig"}). We found that *Bmp4* and *Lfng* were expressed in severely malformed mutant cochlea ([Figs. 2D and 2H](#f2-molce-41-7-695){ref-type="fig"}, arrowheads). We also observed that *Atoh1*, a master regulator for hair cell specification, was expressed in the sensory patches of malformed inner ears ([Figs. 2K and 2L](#f2-molce-41-7-695){ref-type="fig"}). These results suggest that although loss of CTCF severely affects inner ear morphogenesis, sensory specification is preserved.

Next, we sought to determine whether the development of spiral ganglion neurons is affected by the loss of CTCF. *Foxg1*, which is expressed in the delaminating spiral ganglia ([Fig. 2N](#f2-molce-41-7-695){ref-type="fig"}, arrows) and the medial side of cochlear epithelium ([Fig. 2N](#f2-molce-41-7-695){ref-type="fig"}, arrowheads), was used as a neuronal marker ([@b9-molce-41-7-695]). In *Ctcf* cKO ears, while *Foxg1* expression in the cochlear epithelium was detected ([Fig. 2P](#f2-molce-41-7-695){ref-type="fig"}, arrowheads), it was completely downregulated in the mesenchymal region where spiral ganglion neurons are normally localized ([Fig. 2P](#f2-molce-41-7-695){ref-type="fig"}, red asterisk), indicating a complete loss of spiral ganglion neurons in the absence of CTCF. These results suggest that CTCF is required for the differentiation or survival of spiral ganglion neurons in the developing inner ear.

Changes in gene expression upon *Ctcf* deletion in otocysts
-----------------------------------------------------------

The complete lack of spiral ganglion neurons in the inner ears of *Ctcf*-deficient mouse embryos prompted us to perform microarray-based gene expression analyses to identify genes regulated by CTCF in otocysts at E10.5. Among 279 genes exhibiting significantly different expression levels between control and mutant otocysts (≥ two-fold, *p* \< 0.01), 269 genes were downregulated and 10 genes were upregulated ([Fig. 3A](#f3-molce-41-7-695){ref-type="fig"}; [Supplementary Table S1](#s2-molce-41-7-695){ref-type="supplementary-material"}). When subjected to DAVID functional annotation clustering analysis, genes differentially expressed in the otocysts from *Ctcf*-deficient embryos were enriched primarily in neurogenesis-related clusters, such as neuron projection (clusters 1 and 2), neuron differentiation (clusters 2 and 4), and neuron development (clusters 2 and 4) ([Supplementary Table S2](#s1-molce-41-7-695){ref-type="supplementary-material"}). Consistent with our microarray results, quantitative real-time PCR (qPCR) revealed significant reductions in the expression levels of selected genes, including *Ctcf, Neurog1, and Neurod1,* but not *Tbx1,* in *Ctcf* cKO otocysts, compared to controls ([Figs. 3B--3E](#f3-molce-41-7-695){ref-type="fig"}).

Additionally, we analyzed the expression domains of the genes significantly altered by loss of *Ctcf* with immunofluorescence and *in situ* hybridization. Immunofluorescence signals for CTCF were specifically decreased in the otic epithelium of *Ctcf* cKO otocysts, but not the surrounding mesenchyme ([Figs. 3F and 3G](#f3-molce-41-7-695){ref-type="fig"}). The expression domains of *Neurog1* and *Neurod1* were greatly decreased in *Ctcf* cKO otocysts ([Figs. 3H--3K](#f3-molce-41-7-695){ref-type="fig"}). Moreover, the expressions of *Nhlh1*, *Stmn2*, and *Dcx*, which were expressed in delaminating neuroblasts, were also greatly reduced in *Ctcf* cKO otocysts ([Supplementary Fig. S1](#s1-molce-41-7-695){ref-type="supplementary-material"}). These results suggest that CTCF plays an essential role in neurogenesis in the otocyst by regulating genes important for early neurogenesis.

CTCF is required for the expression of neurogenic, but not prosensory, genes
----------------------------------------------------------------------------

In light of the above, we wondered whether the gene expression changes arising in the absence of CTCF are specific to neurogenic genes. When examined by whole-mount *in situ* hybridization, the expression domains of *Neurog1* and *Neurod1*, which are normally observed in the anteroventral aspects of the otocyst at E9.5 ([Figs. 3N and 3P](#f3-molce-41-7-695){ref-type="fig"}; black bracket and white dotted lines), were greatly decreased in the *Ctcf* cKO otocysts ([Figs. 3O and 3Q](#f3-molce-41-7-695){ref-type="fig"}, red brackets and dotted lines). In contrast, expression of *Tbx1*, which is normally expressed in the posterior otocyst and inhibits neurogenesis by suppressing the expression of neurogenic genes ([@b11-molce-41-7-695]), was not altered in the mutant otocysts ([Figs. 3R and 3S](#f3-molce-41-7-695){ref-type="fig"}). This result indicates that the compromised neurogenesis noted in *Ctcf*-deficient otocysts is not due to misregulation of *Tbx1*. In addition, the expressions of genes important for sensory specification, such as *Sry-related HMG-box 2* (*Sox2*) and *Lfng*, were also generally unaffected in *Ctcf* cKO otocysts ([Figs. 3T--3W](#f3-molce-41-7-695){ref-type="fig"}; arrows and dotted lines). These results indicate that, in the *Ctcf*-deficient otocyst, otic neurogenesis is affected most likely by specific downregulation of neurogenic genes, such as *Neurog1* and *Neurod1*, but not by global misregulation of genes important for inner ear development.

Regulation of *Neurog1* gene expression by CTCF is associated with changes in histone modification
--------------------------------------------------------------------------------------------------

Our analyses of the inner ear from *Ctcf* cKO mouse embryos showed that CTCF is required for the expression of genes associated with neurogenesis, including *Neurog1*. To investigate the role of CTCT in the regulation of *Neurog1* during neuronal differentiation, we knocked down CTCF expression in P19 embryonal carcinoma cells, which differentiate into a neuronal fate upon treatment with RA through *Neurog1* induction ([@b3-molce-41-7-695]). In the *Ctcf*-diminished P19 cells, upregulation of *Neurog1* expression by RA treatment was significantly compromised, compared to control cells ([Fig. 4B](#f4-molce-41-7-695){ref-type="fig"}, P \< 0.01). These results indicated that CTCF is required for *Neurog1* expression in P19 cells *in vitro* and that the P19 neuronal differentiation model is suitable for studying the regulatory mechanism of CTCF in relation to *Neurog1* expression.

Genome-wide CTCF occupancy patterns, which have been mapped across more than 100 mammalian cell types, revealed prominent CTCF binding to the −14.4 kb and −7.6 kb transcription start sites of *Neurog1* ([Fig. 4A](#f4-molce-41-7-695){ref-type="fig"}). We performed ChIP-qPCR analysis to validate the *in vivo* binding of CTCF in P19 cells, and observed strong occupancy of CTCF to these binding sites ([Fig. 4C](#f4-molce-41-7-695){ref-type="fig"}). RA treatment did not abolish this pattern of CTCF binding to the *Neurog1* locus, suggesting that CTCF binds to these binding sites constitutively, regardless of *Neurog1* expression ([Fig. 4C](#f4-molce-41-7-695){ref-type="fig"}).

As histone modification contributes to distinct chromatin states and gene expression, we attempted to determine whether CTCF is involved in histone modifications of the *Neurog1* locus during neuronal differentiation of P19 cells. In control cells, the enrichment of H3K27Ac, an active enhancer marker, was significantly increased at the *Neurog1* promoter, as well as other enhancers, upon RA treatment. However, under the same conditions, H3K27Ac levels at the *Neurog1* promoter prominently decreased in CTCF-diminished P19 cells ([Fig. 4D](#f4-molce-41-7-695){ref-type="fig"}). These results suggest an epigenetic dependence on *Neurog1* expression and that neuronal differentiation is regulated by H3K27 acetylation in the *Neurog1* locus.

DISCUSSION
==========

In this study, by analyzing inner ear-specific *Ctcf* knockout mouse embryos, we discovered that CTCF plays essential roles in inner ear development. The *Ctcf*-deficient inner ears exhibited severe morphological defects both in the vestibule and cochlea. Interestingly, we observed that, while sensory specification was preserved in the malformed inner ears, neuronal specification was greatly reduced. The compromised neurogenesis was due to downregulation of neurogenic gene expression, particularly *Neurog1* and *Neurod1,* in the inner ear primordium. Moreover, we found that CTCF regulates *Neurog1* expression by directly binding to enhancer sequences at the *Neurog1* locus and by modulating histone modifications.

Neurosensory specficiation in the anterior aspect of the inner ear primordium is one of the earliest and most important processes in inner ear development ([@b18-molce-41-7-695]). This specification establishes the anteroposterior axis of the developing inner ear, which guides the subsequent development of sensory patches of the inner ear. The anterior crista and utricular macula are specified within the neurosensory domain, whereas the posterior crista is specified outside the domain. This neurosensory specification is directed by anteriorly restricted expression of genes important for sensory specification, such as *Sox2* and *Lfng*, and for neurogenesis, such as *Neurog1* and *Neurod1* ([@b1-molce-41-7-695]). Since the expression domains for these neurogenic and prosensory genes overlap in the anterior aspect of the otocyst and since the two specification processes occur simultaneously during early stages of inner ear development, one could postulate that the expressions of these genes would be regulated by a common mechanism. However, our results demonstrated that, in *Ctcf*-deficient otocysts, while the expressions of neurogenic genes, such as *Neurog1, Neurod1*, *Stmn2*, and *Dcx*, were greatly reduced, those important for sensory specification, such as *Sox2* and *Lfng*, were generally unaffected ([Figs. 1](#f1-molce-41-7-695){ref-type="fig"} and [3](#f3-molce-41-7-695){ref-type="fig"}; [Supplementary Fig. S1](#s1-molce-41-7-695){ref-type="supplementary-material"}). These results suggest that these two specification processes are regulated independently from one another and occur as separate events.

Epigenetic regulations in inner ear development have recently been reported. In the inner ear of chickens, epigenetic modifiers, such as the DNA methyltransferase DNMT3A and the histone demethylase KDM4B, were shown to be important for proper formation and invagination of the otic placode, respectively ([@b12-molce-41-7-695]; [@b16-molce-41-7-695]). In the present study, we demonstrated that the chromatin architecture protein CTCF also plays a critical role in otic neurogenesis by regulating *Neurog1* gene expression. In particular, histone acetylation in the promoter and enhancer sequences of the *Neurog1* locus was found to be closely associated with CTCF*.* Given the constitutive binding of CTCF in the *Neurog1* locus, we suggest that the observed induction of *Neurog1* expression upon RA treatment would require other regulatory factors, which remains to be elucidated in future studies.

In our *Ctcf* cKO mutants, the shapes of the otocysts were relatively normal, from which we discerned that CTCF does not seem to be involved in placodal induction and invagination. The normal otocyst formation could be due to late onset of Cre recombinase expression in the developing inner ear, which is driven by the *Pax2-Cre* transgene in the *Ctcf* cKO mutants. However, since Cre recombinase activity is detected in the otic placode from the 6--7 somite stages in *Pax2-Cre* mice ([@b6-molce-41-7-695]), CTCF does not appear to play a major role in placodal specification and invagination. In addition, in the mammalian inner ear, the epigenetic states of histone modifications in the *Atoh1* locus are dynamically changed during hair cell differentiation and maturation ([@b15-molce-41-7-695]). However, we observed *Atoh1* expression in the malformed *Ctcf* cKO inner ears, suggesting that CTCF does not play a major role in *Atoh1* expression in the developing inner ear.

Depletion of *Ctcf* has been shown to increase cell death in the limb and brain ([@b2-molce-41-7-695]; [@b14-molce-41-7-695]; [@b17-molce-41-7-695]). Consistent therewith, we also observed massive cell death among the otocysts of *Ctcf* cKO mouse embryos ([Fig. 2](#f2-molce-41-7-695){ref-type="fig"}). Meanwhile, although upregulation of p53-dependent transcriptional activation of *Puma* has been observed in the *Ctcf*-deficient brain ([@b17-molce-41-7-695]), the levels of *Puma* in the present study were not altered in the *Ctcf* cKO embryos upon microarray analysis, suggesting that the mechanism of cell death elicited by the *Ctcf* loss is tissue specific. In addition to increased cell death, we also observed decreased cell proliferation in the *Ctcf*-deficient otocyst ([Fig. 2](#f2-molce-41-7-695){ref-type="fig"}). This could be secondarily caused by downregulation of *Neurog1*, which was previously shown to promote cell proliferation by regulating *Cdk2* in immortalized multipotent otic progenitor cells ([@b13-molce-41-7-695]). These results suggest that CTCF is required for cell survival and proliferation in the otocyst, which may account for the abnormal morphogenesis noted in the inner ear of *Ctcf*-deficient mouse embryos.

In summary, we identified a role for CTCF during inner ear development by analyzing developing inner ears of *Ctcf*-deficient mouse embryos. Further study is required to fully elucidate the underlying mechanism of how CTCF controls inner ear development by modulating chromatin architecture and also to examine the possible roles of CTCF in the maintenance and hearing functions of the mature inner ear.
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![Analyses of gross morphology at E14.5 and cell survival and proliferation in *Pax2-Cre*; *Ctcf^fl/+^* and *Pax2-Cre*; *Ctcf^fl/fl^* otocysts at E10.5\
(A--F) Gross morphology of the inner ears of *Pax2-Cre; Ctcf^fl/+^* (A--C) and *Pax2-Cre; Ctcf^fl/fl^* (D--F) mouse embryos were examined by the paint-fill technique at E14.5. (D--F) In *Pax2-Cre; Ctcf^fl/fl^* inner ears, the anterior and lateral semicircular canals and ampullae were absent. The cochlear duct was stunted with an abnormal coiling structure. (G, I, K, M) TUNEL-positive cells increased markedly in number in *Pax2-Cre; Ctcf^fl/fl^* otocysts, compared to *Pax2-Cre; Ctcf^fl/+^* otocysts (red dotted line). (H, J, L, N) Fewer EdU-labeled cells were noted in *Pax2-Cre; Ctcf^fl/fl^* otocysts, compared to *Pax2-Cre; Ctcf^fl/+^* otocysts (white dotted line). Blue dotted lines in the otocyst diagram indicate section planes shown in (G)--(N). Abbreviations: aa, anterior ampulla; asc, anterior semicircular canal; la, lateral ampulla; lsc, lateral semicircular canal; u, utricle; s, saccule; co, cochlear duct; psc, posterior semicircular canal; A, anterior; D, dorsal; L, lateral. Scale bars AF, 300 μm; G--N, 100 μm.](molce-41-7-695f1){#f1-molce-41-7-695}

![Gene expression patterns of neurosensory genes in *Pax2-Cre*; *Ctcf^fl/+^* and *Pax2-Cre*; *Ctcf^fl/fl^* mutant embryos at E14.5\
(A--P) Expression patterns of *Bmp4* (A--D), *Lfng* (D--H), *Atoh1* (I--L), and *Foxg1* (M--P) were examined by *in situ* hybridization in *Pax2-Cre; Ctcf^fl/+^* and *Pax2-Cre; Ctcf^fl/fl^* embryos at E14.5. Upper diagrams indicate the section planes shown in A--P. In *Pax2-Cre; Ctcf^fl/fl^* inner ears, the expressions of *Bmp4* (D), *Lfng* (G, H), *Atoh1* (K, L), and *Foxg1* (O, P) in the epithelium were present (arrows and arrowheads), whereas *Foxg1* expression in the spiral ganglia was lost (P; red asterisk). u, utricle; lc, lateral cristae; co, cochlea; pc, posterior cristae; SG, spiral ganglia. A--P, 200 μm.](molce-41-7-695f2){#f2-molce-41-7-695}

![Otic neurogenesis is decreased in *Pax2-Cre*; *Ctcf^fl/fl^* otocysts\
(A) Heat map represents the relative mRNA expression levels analyzed by microarray analyses from *Pax2-Cre; Ctcf^fl/+^* (control) and *Pax2-Cre; Ctcf^fl/fl^* (*Ctcf* cKO) otocysts at E10.5. (B--E) Validation of gene expression levels by quantitative real-time PCR. \*p \< 0.05; \*\*\*p \< 0.001. (F, G) Immunostaining with anti-CTCF antibody in E10.5 otocysts. CTCF-positive cells (green) were greatly reduced in *Pax2-Cre; Ctcf^fl/fl^*, compared with *Pax2-Cre; Ctcf^fl/+^* otocysts. White asterisk indicates loss of otic neuroblasts. (H--M) Reduced expression of *Neurog1* and *Neurod1* (I, K; red asterisk), but not *Tbx1* (M)*,* in *Pax2-Cre; Ctcf^fl/fl^* otocysts was confirmed by *in situ* hybridization at E10.5. Red dotted line in the left upper diagram indicates section plane for *in situ* hybridization. (N--W) Expression of *Neurog1*, *Neurod1*, *Tbx*, *Sox2*, and *Lfng* was examined by whole-mount *in situ* hybridization in *Pax2-Cre; Ctcf^fl/+^* (N, P, R, T, V) and *Pax2-Cre; Ctcf^fl/fl^* (O, Q, S, U, W) embryos at E9.5. Expressions of *Neurog1* and *Neurod1,* which were observed in the anterior otic vesicle and delaminating neuroblasts in *Pax2-Cre; Ctcf^fl/+^* otocysts (N, P; black bracket and dotted line), were severely reduced in *Pax2-Cre; Ctcf^fl/fl^* otocysts (O, Q; red bracket and dotted line). (R--W) Expression of *Tbx1* in the posterior otocyst (R, S) and *Sox2* and *Lfng* in the anterior otocyst was observed in both *Pax2-Cre; Ctcf^fl/+^* (T, V; arrow and dotted line) and *Pax2-Cre; Ctcf^fl/fl^* (U, W; arrow and dotted line) embryos. Scale bars (F--M), 100 μm; (N--W), 50 μm.](molce-41-7-695f3){#f3-molce-41-7-695}

![Change in H3K27Ac at the *Neurog1* locus upon CTCF knockdown during RA-induced differentiation of P19 cells\
(A) Schematic representation of CTCF binding sites and enhancers in the mouse *Neurog1* locus. Red triangles and gray boxes indicate CTCF binding sites and enhancers. Black arrows indicate the direction of transcription of *Neurog1* (black box). (B) P19 cells were transfected with siRNA against *ctcf*, and qRT-PCR was performed to analyze mRNA levels of *Ctcf* and *Neurog1* normalized against Rpl7 levels. (C) P19 cells were cultured for 3 days in the absence (−RA) or in the presence of RA (+RA), and were subjected to ChIP analysis with CTCF antibody. (D) P19 cells transfected with siRNA against *ctcf* were cultured for 3 days in the absence (−RA) or in the presence of RA (+RA), and were subjected to ChIP analysis with anti-H3K27Ac antibody. The enrichment of H3K27Ac was analyzed by qPCR with the ChIP primers (black rectangles). \*\*\*p \< 0.001.](molce-41-7-695f4){#f4-molce-41-7-695}
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